Ophthalmology Associates

Fort Worth, Texas 76102

2 studies enrolling now · 16 studies all time

What they study most

Age-related Macular Degeneration, Cataract, Glaucoma, Glaucoma and Ocular Hypertension, Glaucoma, Open-Angle, Macular Degeneration, Neovascular (Wet) Age-related Macular Degeneration (AMD), Open Angle Glaucoma, Open-Angle Glaucoma, Open-angle Glaucoma, Primary Open Angle Glaucoma, Primary Open-angle Glaucoma

Studies at this site

• Change in IOP Fluctuation After DSLT — Recruiting now
• Clarifying the Optimal Application of SLT Therapy Trial — Recruiting now
• Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes — Running, not enrolling
• Hydrus Microstent for Refractory Open-Angle Glaucoma — Completed
• Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma — Stopped early
• Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma. — Running, not enrolling
• A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD] — Completed
• STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma — Status unconfirmed
• Study of OMNI System in OAG (GEMINI) — Completed
• ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA — Completed
• Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent — Completed
• PRESERFLO® MicroShunt Extension Study — Completed
• A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study — Completed
• InnFocus MicroShunt Versus Trabeculectomy Study — Completed
• iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study — Status unconfirmed
• Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration — Completed